manuscripts-shuwatu.blogspot.com
The private, nonprofit group’s role in the May 18-21 conference, whicb is being held for the first time in the indicates how the organization has grown and expandec its scope since it beganin 1989. It follows a move to re-invent itself that was markee with changing its name last year from the Georgia Biomedicalp Partnership toGeorgia Bio. “We felt that with the name GeorgizBiomedical Partnership, people only thought that we were promotingf the interest of the companies and organizations involvecd in applying life sciences technology to said Charles Craig, president of Georgia Bio.
The nonprofit’s membershipo has doubled in the past five years to some 300 including pharmaceutical, biotech and medicakl device companies, as well as universities, research government groups and They range in expertise from health care and agriculturse to industrial and bioenergy production and environmentall management. “When it comes to the life science all applications of it are representeed herein Georgia,” Craig said. Board members represent some ofthe state’ s largest life sciences companies, such as , , and and , and emerginhg firms such as The groupp works to represent and promote the interest of the life sciencea in Georgia.
Georgia Bio is serving on the frontline in preparationn forBIO 2009, said Fabrice Egros, presidenty of Atlanta-based biopharmaceutical company UCB, the Norty American subsidiary for Brussels-based UCB S.A. The conferences is expected to bring morethan 20,000 people from 70 nationas and 48 states. As the stats affiliate for the Biotechnology Industry Organization and a membef of the Council of State Bioscience Georgia Bio isthe conference’s local Egros, co-chairman of the board for Georgiq Bio, said the 2009 convention is important to Georgia becoming a leader in life sciences. “BIO is one step,” he said.
“That’ s where we will create the awarenesds ofGeorgia ... companiees in our care.”
No comments:
Post a Comment